26.08.2022 • NewsArxadaDSMcarbon footprint

Arxada Expands at Visp to Continue Supplying DSM

Swiss specialty chemicals company Arxada said it will invest 20 million Swiss francs to expand production at its Visp site following the extension of a long-term supply partnership with DSM.

Arxada supplies niacin and various other nutritional ingredients to DSM’s vitamin and aroma ingredients business in neighboring Visp-Lalden. The company will also make further investments to cut Visp’s carbon footprint so as to help meet both firms’ sustainability commitments.

“This significant new investment in our Visp facility secures the site’s long-term future, helping to fuel our future growth, and demonstrates our clear commitment to sustainability and reducing our carbon footprint,” said Antje Gerber, Arxada’s president, specialty products solutions.

Arxada did not give a start-up date for the expansion. The Basel-based firm said it had already made a “significant” investment at the site last year to reduce greenhouse gas emissions.

Author: Elaine Burridge, Freelance Journalist

©lichtmeister/Shutterstock
©lichtmeister/Shutterstock

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.